C. Hill and F. Doyon, Epidémioiogie des cancers, Bull Cancer, vol.84, issue.9, pp.917-925, 1997.

F. Menegoz, Cancer incidence and mortality in France in 1975???95, European Journal of Cancer Prevention, vol.6, issue.5, pp.442-66, 1997.
DOI : 10.1097/00008469-199710000-00005

A. Rezvani and C. Hill, Variations géographiques et temporelles de la mortalité par cancer bronchique en France. in 19ème réunion scientifique de l'Associatton des Epidémiologistes de Langue Française, 1994.

F. Berrino, R. Capocaccia, and J. Esteve, Survival ofcancer patients in Europe

. Study, Lyon: Scientific Publications. 6. Roffo, A.H., Der Tabakals krebserzeugendeAgens, Dtsch Med Wochnschr, vol.63, pp.1267-71, 1937.

A. H. Roffo, Krebserzeugendes Benzpyren, gewonnen aus Tabakteer, Zeitschrift f??r Krebsforschung, vol.30, issue.5, pp.588-97, 1939.
DOI : 10.1042/bj0300704

E. Wynder and E. A. Graham, Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma. A study ofsix hundred and eighty-four proved cases, Jama, issue.143, pp.329-375, 1950.

R. Doli and A. B. Hill, A study ofthe aetiology ofcarcinoma ofthe lung, BMJ, issue.2, pp.1271-86, 1952.

R. Doli and R. Peto, Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers., Journal of Epidemiology & Community Health, vol.32, issue.4, pp.303-316, 1978.
DOI : 10.1136/jech.32.4.303

J. H. Lubin, Patterns of lung cancer risk according to type of cigarette smoked, International Journal of Cancer, vol.62, issue.5, pp.569-76, 1984.
DOI : 10.1002/ijc.2910330504

R. Doli, Mortality in relation to smoking: 40 years' observations on male British doctors, BMJ, vol.309, issue.6959, pp.901-912, 1994.
DOI : 10.1136/bmj.309.6959.901

Y. Martinet and A. Bohadana, Le tabagisme: de la prévention au sevrage. Abrégés, 1997.

O. Menard, Residential radon exposure and lung cancer in Sweden, Radon et cancer bronchique primitif Rev Mal Respir N Engl J Med, vol.11, issue.153, pp.531-576, 1994.

J. J. Moulin, A meta-analysis of epidemiologic studies of lung cancer in welders, Scandinavian Journal of Work, Environment & Health, vol.23, issue.2, pp.104-117, 1997.
DOI : 10.5271/sjweh.187

C. F. Mountain, Revisions in the International System for Staging Lung Cancer, Chest, vol.111, issue.6, pp.1710-1717, 1997.
DOI : 10.1378/chest.111.6.1710

N. Martini, Management of non-small cell lung cancer with direct mediastinal involvement, The Annals of Thoracic Surgery, vol.58, issue.5, pp.1447-51, 1994.
DOI : 10.1016/0003-4975(94)91933-X

F. G. Pearson, Current Status of Surgical Resection for Lung Cancer, Chest, vol.106, issue.6, pp.337-339, 1994.
DOI : 10.1378/chest.106.6_Supplement.337S

G. L. Walsh, 1sfollow-up oflung cancer patients af/er resection medically indicated and costeffective? Ann Thorac Surg, pp.1563-70, 1995.
DOI : 10.1016/0003-4975(95)00893-4

P. C. Pairolero, Postsurgical Stage I Bronchogenic Carcinoma: Morbid Implications of Recurrent Disease, The Annals of Thoracic Surgery, vol.38, issue.4, pp.331-339, 1984.
DOI : 10.1016/S0003-4975(10)62281-3

H. Morton and R. E. Lv-dales, tobacco smoking and pulmonary complications af/er surgery Preoperative prediction ofpulmonary complications following thoracic surgery, Lancet Chest, vol.23, issue.1041, pp.368-70, 1944.

T. Ishida, Long-term results of operation for non-small cell lung cancer in the elderly, The Annals of Thoracic Surgery, vol.50, issue.6, pp.919-941, 1990.
DOI : 10.1016/0003-4975(90)91119-V

K. Inoue, Prognostic assessment of 1310 patients with non???small-cell lung cancer who underwent complete resection from 1980 to 1993, The Journal of Thoracic and Cardiovascular Surgery, vol.116, issue.3, pp.407-418, 1998.
DOI : 10.1016/S0022-5223(98)70006-6

M. H. Gail, Prognostic factors in patients with resected stage I non-small cell lung cancer. A report from the Lung Cancer Study Group, Cancer, vol.44, issue.9, pp.1802-1815, 1984.
DOI : 10.1016/0014-2964(79)90291-3

E. H. Lipford, Prognostic factors in surgically resected limited-stage, nonsmall cell carcinoma of the lung, The American Journal of Surgical Pathology, vol.8, issue.5, pp.357-65, 1984.
DOI : 10.1097/00000478-198405000-00004

L. Sorensen and J. H. Badsberg, Prognosticfactors in resected stages 1 and 11adenocarcinoma ofthe lung. A multivariate regression analysis of137 consecutive patients, J Thorac Cardiovasc Surg, vol.99, issue.2, pp.218-244, 1990.

R. Mckenna and . Jr, Roentgenographic Evaluation of Mediastinal Nodes for Preoperative Assessment in Lung Cancer, Chest, vol.88, issue.2, pp.206-216, 1985.
DOI : 10.1378/chest.88.2.206

M. Riquet, O. Hidden, B. Debesse-ginsberg, R. , and L. V. Rubinstein, Direct lymphatic drainage oflung segments to the mediastinal nodes An anatomie study on 260 adults Randomized trial oflobectomy versus limited resectionfor Tl NO non-small ceillung cancer. Lung Cancer Study Group, J Thorac Cardiovasc Surg Ann Thorac Surg, vol.97, issue.833, pp.623-655, 1989.

J. R. Izbicki, Accuracy ofcomputed tomographie scan and surgical assessmentfor staging of bronchial carcinoma. A prospective study, J Thorac Cardiovasc Surg, vol.104, issue.2, pp.413-433, 1992.

W. Lewis and . Jr, Can computed tomography of the chest stage lung cancer????Yes and no, The Annals of Thoracic Surgery, vol.49, issue.4, pp.591-596, 1990.
DOI : 10.1016/0003-4975(90)90306-Q

A. Gdeedo, Comparison of imaging TNM [(i)TNM] and pathological TNM [pTNM] in staging of bronchogenic carcinoma, Regionallymph node classification for lung cancer staging. Chest, pp.224-7111, 1997.
DOI : 10.1016/S1010-7940(97)00084-5

1. Schirren, Chirurgie du carcinome bronchique avec envahissement nodulaire médiastinal, Ann Chir, vol.48, issue.9, pp.852-61, 1994.

F. O. Pearson, Significance ofpositive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer ofthelung Prognosis ofunsuspected but completely resectable N2 non-small celliung cancer, J Thorac Cardiovasc Surg Ann Thorac Surg, vol.83, issue.12, pp.56-300, 1982.

N. Martini, Prognostic significance ofNI disease in carcinoma ofthe lung, J Thorac Cardiovasc Surg, vol.86, issue.5, pp.646-53, 1983.

N. Roeslin, Irradiation complémentaire pour cancer bronchique, Ann Chir, vol.40, issue.2, pp.89-95, 1986.

L. Regnard, Results ofresectionfor bronchogenic carcinoma with mediastinallymph node metastases in selected patients Validation ofthe TNM classification (4th edn) for lung cancer: first results ofa prospective study of 1086 patients with surgicaltreatment, Eur J Cardiothorac Surg Eur J Cardiothorac Surg, issue.511 57, pp.583-589, 1991.

N. Roeslin, Résultats de la chirurgie du cancer bronchique non anaplasique Analyse critique de la survie, Ann Chir, issue.6, pp.41-469, 1987.

N. Martini, Incidence of local recurrence and second primary tumors in resected stage I lung cancer, The Journal of Thoracic and Cardiovascular Surgery, vol.109, issue.1, pp.120-129, 1995.
DOI : 10.1016/S0022-5223(95)70427-2

N. Martini, Results of Resection in Non-Oat Cell Carcinoma of the Lung with Mediastinal Lymph Node Metastases, Annals of Surgery, vol.198, issue.3, pp.386-97, 1983.
DOI : 10.1097/00000658-198309000-00015

R. Ginsberg, Modern thirty-day operative mortality for surgical resections in lung cancer, J Thorac Cardiovasc Surg, vol.86, issue.5, pp.654-662, 1983.

N. Roeslin and O. Morand, Complications et mortalité de la chirurgie du cancer bronchique, Rev Pneumol Clin, vol.48, issue.5, pp.231-237, 1992.

F. Stephan, Pulmonary Complications Following Lung Resection, Chest, vol.118, issue.5, pp.1263-70, 2000.
DOI : 10.1378/chest.118.5.1263

L. Bourgeois, F. Chavaudra, . Eschwege, and O. H. Radiothérapie-oncologique-fletcher, Hermann: Science et pratique médicales Clinical dose response curves ofhuman malignant epithelialtumours, Br J Radiol, vol.102, issue.542, pp.46-151, 1973.

C. A. Perez, Impact ofirradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma ofthe lung: report by the Radiation Therapy Oncology Group. Cancer, l04. ICRU, Prescribing, Recording and Reporting Photon Beam therapy. 1993, International Comission on Radiation Units and Measurements: Bethesda. 105. ICRU, Prescribing, Recording and Reporting Photon Beam therapy International Comission on Radiation Units and Measurements: Bethesda, pp.1091-1100, 1982.

F. Mornex, Radiothérapie du cancer bronchique non à petites cellules: définitions des volumes, sélection des patients Recommendations de l'International Associationfor the Study ofLung Cancer l8F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis, Cancer Radiother Int J Radiat Oncol Biol Phys, issue.253, pp.579-8944, 1998.

F. Vaylet, Apport de la tomographie par émission de positons à la radiothérapie thoracique, Cancer Radiother, issue.4Supp11, pp.13-19, 2000.

L. Vanuytse1, The impact of(l8)F-jluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small celliung cancer, Radiother Oncol, issue.3, pp.55-317, 2000.

P. Giraud, CT and (18)F-deoxyglucose (FDG) image fusion for optimization ofcorformal radiotherapy oflung cancers, 1nt J Radiat Onco1 Biol Phys, issue.5, pp.49-1249, 2001.

P. Giraud, Evaluation of microscopic tumor extension in non???small-cell lung cancer for three-dimensional conformal radiotherapy planning, International Journal of Radiation Oncology*Biology*Physics, vol.48, issue.4, pp.1015-1039, 2000.
DOI : 10.1016/S0360-3016(00)00750-1

R. Chan, Evaluation ofmicroscopie tumor extension in non-small-celliung cancer for three-dimensional conformal radiotherapy planning, URGBP Int J Radiat Oncol Biol Phys, vol.48, issue.534, pp.1015-1024, 2000.

C. Ross, Analysis of movement of intrathoracic neoplasms using ultrafast computerized tomography, International Journal of Radiation Oncology*Biology*Physics, vol.18, issue.3, pp.671-678, 1990.
DOI : 10.1016/0360-3016(90)90076-V

P. Giraud, Conformal radiotherapy (CRT) planning for lung cancer: analysis of intrathoracic organ motion during extreme phases of breathing, International Journal of Radiation Oncology*Biology*Physics, vol.51, issue.4, pp.1081-92, 2001.
DOI : 10.1016/S0360-3016(01)01766-7

L. Ekberg, What margins should be added to the clinical target volume in radiotherapy treatment planning for lung cancer? Radiother Oncol, pp.71-77, 1998.

Y. Seppenwoolde, Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.53, issue.4, pp.822-856, 2002.
DOI : 10.1016/S0360-3016(02)02803-1

S. C. Erridge, Portal imaging to assess set-up errors, tumor motion and tumor shrinkage during conformal radiotherapy of non-small cell lung cancer, Radiotherapy and Oncology, vol.66, issue.1, pp.75-85, 2003.
DOI : 10.1016/S0167-8140(02)00287-6

J. Van-de-steene, Electronic Portal Imaging with On-Line Correction of Setup Error in Thoracic Irradiation: Clinical Evaluation, International Journal of Radiation OncologyBiologyPhysics, vol.40, issue.4, pp.967-76, 1998.
DOI : 10.1016/S0360-3016(97)00925-5

S. Essapen, Accuracy of set-up of thoracic radiotherapy: prospective analysis of 24 patients treated with radiotherapy for lung cancer, The British Journal of Radiology, vol.75, issue.890, pp.162-171, 2002.
DOI : 10.1016/S0360-3016(00)00625-8

R. Ha1perin, Setup reproducibility in radiation therapy for lung cancer: a comparison between T-bar and expanded foam immobilization devices, International Journal of Radiation Oncology*Biology*Physics, vol.43, issue.1, pp.211-217, 1999.
DOI : 10.1016/S0360-3016(98)00354-X

L. Rosenman, High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: technical issues and results of a phase I/II trial, International Journal of Radiation Oncology*Biology*Physics, vol.54, issue.2, pp.348-56, 2002.
DOI : 10.1016/S0360-3016(02)02958-9

F. Lagerwaard, Has 3-D conformai radiotherapy (3D CRT) improved the local tumour control for stage 1 non-small celliung cancer? Radiother Oncol, pp.151-158, 2002.

M. V. Graham, Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer, International Journal of Radiation Oncology*Biology*Physics, vol.33, issue.5, pp.993-1000, 1995.
DOI : 10.1016/0360-3016(95)02016-0

L. Armstrong, Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer, Radiotherapy and Oncology, vol.44, issue.1, pp.17-22, 1997.
DOI : 10.1016/S0167-8140(97)01907-5

G. S. Sibley, The treatment of stage III nonsmall cell lung cancer using high dose conformal radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.33, issue.5, pp.1001-1008, 1995.
DOI : 10.1016/0360-3016(95)02010-1

F. Mornex, Volume tumoral macroscopique et volume???cible anatomoclinique en radioth??rapie??: cancer bronchique, Cancer/Radioth??rapie, vol.5, issue.5, pp.659-70, 2001.
DOI : 10.1016/S1278-3218(01)00124-X

L. Bonner, Frequency of noncontiguous lymph node involvement in patients with resectable nonsmall cell lung carcinoma, Cancer, vol.62, issue.7, pp.1159-64, 1999.
DOI : 10.1148/radiology.203.1.9122391

L. Robertson, Dose escalation for non-small cell lung cancer using conformal radiation therapy, International Journal of Radiation Oncology*Biology*Physics, vol.37, issue.5, pp.1079-85, 1997.
DOI : 10.1016/S0360-3016(96)00593-7

G. S. Sibley, Radiotherapy Alone for Medically Inoperable Stage I Non-Small???Cell Lung Cancer: The Duke Experience, International Journal of Radiation OncologyBiologyPhysics, vol.40, issue.1, pp.149-54, 1998.
DOI : 10.1016/S0360-3016(97)00589-0

P. C. Cheung, Involved-field radiotherapy alone for early-stage non???small-cell lung cancer, International Journal of Radiation Oncology*Biology*Physics, vol.48, issue.3, pp.703-713, 2000.
DOI : 10.1016/S0360-3016(00)00667-2

K. E. Rosenzweig, Elective nodal irradiation in the treatment of non???small-cell lung cancer with three-dimensional conformal radiation therapy, International Journal of Radiation Oncology*Biology*Physics, vol.50, issue.3, pp.681-686, 2001.
DOI : 10.1016/S0360-3016(01)01482-1

A. D. Krol, Local irradiation alone for peripheral Stage I lung cancer: Could we omit the elective regional nodal irradiation?, International Journal of Radiation Oncology*Biology*Physics, vol.34, issue.2, pp.297-302, 1996.
DOI : 10.1016/0360-3016(95)00227-8

S. Senan, Can elective nodal irradiation be omitted in stage III non-small-celliung cancer? Analysis ofrecurrences in a phase 11study ofinduction chemotherapy and involved-field radiotherapy

P. Giraud, Estimation de la probabilit?? d???envahissement tumoral m??diastinal??: une d??finition statistique du volume???cible anatomoclinique pour la radioth??rapie conformationnelle des cancers bronchiques non ?? petites cellules???, Cancer/Radioth??rapie, vol.5, issue.6, pp.725-761, 2001.
DOI : 10.1016/S1278-3218(01)00135-4

J. O. Armslrong, Target volume definition for three-dimensional conformai radiation therapy oflung cancer, Br J Radial, issue.846, pp.71-587, 1998.

J. W. Wang, The use of active breathing control (ABC) to reduce margin for breathing motion, International Journal of Radiation Oncology*Biology*Physics, vol.44, issue.4, pp.911-919, 1999.
DOI : 10.1016/S0360-3016(99)00056-5

L. Hanley, Deep inspiration breath-hold technique for lung tumors: the potential value of target immobilization and reduced lung density in dose escalation, International Journal of Radiation Oncology*Biology*Physics, vol.45, issue.3, pp.603-614, 1999.
DOI : 10.1016/S0360-3016(99)00154-6

K. E. Rosenzweig, The deep inspiration breath-hold technique in the treatment of inoperable non???small-cell lung cancer, International Journal of Radiation Oncology*Biology*Physics, vol.48, issue.1, pp.81-88, 2000.
DOI : 10.1016/S0360-3016(00)00583-6

R. Garcia, Radioth??rapie des cancers du poumon??: le blocage en inspiration sous contr??le spirom??trique, Cancer/Radioth??rapie, vol.6, issue.1, pp.30-38, 2002.
DOI : 10.1016/S1278-3218(01)00132-9

D. Kim, Held-breath self-gating technique for radiotherapy of non???small-cell lung cancer: A feasibility study, International Journal of Radiation Oncology*Biology*Physics, vol.49, issue.1, pp.43-52, 2001.
DOI : 10.1016/S0360-3016(00)01372-9

E. Ford, Evaluation of respiratory movement during gated radiotherapy using film and electronic portal imaging, International Journal of Radiation Oncology*Biology*Physics, vol.52, issue.2, pp.522-531, 2002.
DOI : 10.1016/S0360-3016(01)02681-5

L. Darnstrup and H. S. Poulsen, Review of the curative role of radiotherapy in the treatment of non-small cell lung cancer, Lung Cancer, vol.11, issue.3-4, pp.153-78, 1994.
DOI : 10.1016/0169-5002(94)90537-1

R. Arriagada, Current Strategies for Radiation Therapy in Non-small Cell Lung Cancer, Chest, vol.112, issue.4, pp.209-213, 1997.
DOI : 10.1378/chest.112.4_Supplement.209S

K. R. Durrant, Comparison oftreatment policies in inoperable branchial carcinoma, Lancet, issue.17702, pp.715-724, 1971.

B. Roswit, The Survival of Patients with Inoperable Lung Cancer: A Large-Scale Randomized Study of Radiation Therapy Versus Placebo, Radiology, vol.90, issue.4, pp.688-97, 1968.
DOI : 10.1148/90.4.688

B. Emami, Three-dimensional treatment planning for lung cancer, International Journal of Radiation Oncology*Biology*Physics, vol.21, issue.1, pp.217-227, 1991.
DOI : 10.1016/0360-3016(91)90180-C

M. B. Hazuka, Results of high-dose thoracic irradiation incorporating beam's eye view display in non-small cell lung cancer: A retrospective multivariate analysis, International Journal of Radiation Oncology*Biology*Physics, vol.27, issue.2, pp.273-84, 1993.
DOI : 10.1016/0360-3016(93)90238-Q

L. Cox, A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11., Journal of Clinical Oncology, vol.8, issue.9, pp.1543-55, 1990.
DOI : 10.1200/JCO.1990.8.9.1543

L. Cox, Interruptions ofhigh-dose radiation therapy decrease long-term survival offavorable patients with unresectable non-small cell carcinoma ofthe lung: analysis of 1244 casesfrom 3

W. T. Sause, Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary Results of a Phase III Trial in Regionally Advanced, Unresectable Non-Small-Cell Lung Cancer, JNCI Journal of the National Cancer Institute, vol.87, issue.3, pp.198-205, 1995.
DOI : 10.1093/jnci/87.3.198

W. Sause, Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer, Chest, vol.117, issue.2, pp.358-64, 2000.
DOI : 10.1378/chest.117.2.358

M. Stuschke and H. D. Thames, Hyperfractionated radiotherapy of human tumors: Overview of the randomized clinical trials, International Journal of Radiation Oncology*Biology*Physics, vol.37, issue.2, pp.259-67, 1997.
DOI : 10.1016/S0360-3016(96)00511-1

M. Saunders, S. Dische, . Continuous, and M. I. Saunders, CHART) in non-small cell carcinoma ofthe bronchus Experience with CHART Continuo us hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-smali-ceillung cancer: a randomised multicentre trial Experience with dose escalation using CHARTWEL (continuous hyperfractionated accelerated radiotherapy weekend less) in non-smali-ceillung cancer, lnt J Radial Oncol Biol Phys Int J Radial Oncol Biol Phys CHART Steering Commit/ee. Lancet Br J Cancer, vol.19350, issue.213907210, pp.1211-578, 1990.

M. I. Saunders, Dose-escalation with CHARTWEL (continuous hyperfractionated accelerated radiotherapy week-end less) combined with neo-adjuvant chemotherapy in the treatment oflocally advanced non-small ceillung cancer, Clin Oncol (R Coll Radial), issue.5, pp.14-352, 2002.

M. Saunders, Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small ceillung cancer: mature data from the randomised multicentre trial, CHARTSteeringcommit/ee. RadiolherOncol, vol.52, issue.2, pp.137-185, 1999.

L. Hayman, Dose escalation in non-small-cell lung cancer using three-dimensional conformai radiation therapy: update ofa phase !trial, J Clin Oncol, vol.19, issue.1, 2001.

B. Jeremic, Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: a randomized study., Journal of Clinical Oncology, vol.14, issue.4, pp.1065-70, 1996.
DOI : 10.1200/JCO.1996.14.4.1065

L. Banner, The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma, Cancer, vol.36, issue.6, pp.1037-1085, 1998.
DOI : 10.1002/(SICI)1097-0142(19980315)82:6<1037::AID-CNCR5>3.0.CO;2-B

D. Bail, A phase 1/1study ofaccelerated radiotherapy with and without carboplatin in nonsmall celliung cancer: an interim toxicity analysis ofthe first 100 patients, Int J Radial Oncol Biol Phys, issue.2, pp.31-267, 1995.

R. Komaki, Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous celliung cancer: failure patterns by cell type in RTOG 88-081ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group, Int J Radial Oncol Biol Phys, issue.3, pp.39-537, 1997.

E. E. Yokes, Randomized phase /1 study ofcisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage I/1B non-small-cell lung cancer: cancer and leukemia group B study 9431, J Clin Oncol, issue.20, pp.20-4191, 2002.

D. R. Gandara, Consolidation Docetaxel After Concurrent Chemoradiotherapy in Stage IIIB Non???Small-Cell Lung Cancer: Phase II Southwest Oncology Group Study S9504, Journal of Clinical Oncology, vol.21, issue.10, pp.2004-2014, 2003.
DOI : 10.1200/JCO.2003.04.197

F. Reboul, [What are the optimal thoracic radiotherapy modalities in limited small celliung cancer? Review ofrecent clinical trials, Cancer Radiother, pp.513-520, 1999.

M. Y. Graham, Clinical dose???volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC), International Journal of Radiation Oncology*Biology*Physics, vol.45, issue.2, pp.323-332, 1999.
DOI : 10.1016/S0360-3016(99)00183-2

L. B. Marks, Physical and biological predictors ofchanges in whole-Iungfunctionfollowing thoracic irradiation, pp.563-570, 1997.

S. L. Kwa, Radiation pneumonitis as afunction ofmean lung dose: an analysis ofpooled data of540 patients, pp.1-9, 1998.
DOI : 10.1016/s0360-3016(98)00196-5

E. D. Yorke, Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy, International Journal of Radiation Oncology*Biology*Physics, vol.54, issue.2, pp.329-368, 2002.
DOI : 10.1016/S0360-3016(02)02929-2

Y. Seppenwoolde, Comparing difJerent NTCP models that predict the incidence ofradiation pneumonitis. Normal tissue complication probability, Int J Radiat Oncol Biol Phys, issue.3, pp.55-724, 2003.

M. S. Anscher, Changes in plasma TGF?? levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis, International Journal of Radiation Oncology*Biology*Physics, vol.30, issue.3, pp.671-677, 1994.
DOI : 10.1016/0360-3016(92)90954-G

Z. Yujaskovic and H. Groen, TGF-beta, radiation-induced pulmonary injury and lung cancer, International Journal of Radiation Biology, vol.76, issue.4, pp.511-517, 2000.
DOI : 10.1080/095530000138510

P. D. Maguire, Clinical and dosimetric predictors of radiation-induced esophageal toxicity, International Journal of Radiation Oncology*Biology*Physics, vol.45, issue.1, pp.97-103, 1999.
DOI : 10.1016/S0360-3016(99)00163-7

S. Hirota, Dosimetric predictors of radiation esophagitis in patients treated for non-small-cell lung cancer with carboplatin/paclitaxel/radiotherapy, International Journal of Radiation Oncology*Biology*Physics, vol.51, issue.2, pp.291-296, 2001.
DOI : 10.1016/S0360-3016(01)01648-0

M. L. Dirkx, Beam intensity modulation for penumbra enhancement in the treatment of lung cancer, International Journal of Radiation Oncology*Biology*Physics, vol.44, issue.2, pp.449-54, 1999.
DOI : 10.1016/S0360-3016(98)00563-X

M. L. Dirkx and B. Heijmen, Beam intensity modulation for penumbra enhancement and field length reduction in lung cancer treatments: a dosimetric study, Radiotherapy and Oncology, vol.56, issue.2, pp.181-189, 2000.
DOI : 10.1016/S0167-8140(00)00188-2

M. Brugmans, Beam intensity modulation to reduce the field sizes for conformal irradiation of lung tumors: a dosimetric study, International Journal of Radiation Oncology*Biology*Physics, vol.43, issue.4, pp.893-904, 1999.
DOI : 10.1016/S0360-3016(98)00489-1

. Van-sornsen-de-koste, An evaluation of two techniques for beam intensity modulation in patients irradiated for stage III non-small cell lung cancer, Lung Cancer, vol.32, issue.2, pp.145-53, 2001.
DOI : 10.1016/S0169-5002(00)00214-2

S. Derycke, Non-coplanar beam intensity modulation allows large dose escalation in stage III lung cancer, Radiotherapy and Oncology, vol.45, issue.3, pp.253-61, 1997.
DOI : 10.1016/S0167-8140(97)00132-1

S. Derycke, Conformal radiotherapy of stage III non???small cell lung cancer: a class solution involving non???coplanar intensity-modulated beams, International Journal of Radiation Oncology*Biology*Physics, vol.41, issue.4, pp.771-778, 1998.
DOI : 10.1016/S0360-3016(98)00114-X

L. Moelle, totalité de l'acquisition) et l' oesophage (tous les 2 cm , totalité de la structure)

C. Irradiation, RX DE 10 MV DE PREFERENCE Les faisceaux et les caches sont déterminés autour des PTV et ne dépendent plus que de la géométrie du faisceau

R. Des and . De-contrôle, Simulation virtuelle: séance bianche Actuellement 1 controle par champ suffit si la marge de repositionnement est respectée

J. Armstrong and C. Mcgibney, The impact of three-dimensional radiation on the treatment of non-small cell lung cancer, Radiotherapy and Oncology, vol.56, issue.2, pp.157-67, 2000.
DOI : 10.1016/S0167-8140(00)00207-3

J. Chavaud-ra, Derni??res recommandations de l'ICRU pour la prescription, l'enregistrement et le compte rendu de la radioth??rapie externe, Cancer/Radioth??rapie, vol.2, issue.5, pp.607-621, 1998.
DOI : 10.1016/S1278-3218(98)80104-2

L. Ekberg and O. Holmberg, What margins should be added to the clinical target volume in radiotherapy treatment planning for lung cancer?, Radiotherapy and Oncology, vol.48, issue.1, pp.71-78, 1998.
DOI : 10.1016/S0167-8140(98)00046-2

B. Emami and J. Lyman, Tolerance of normal tissue to therapeutic irradiation, International Journal of Radiation Oncology*Biology*Physics, vol.21, issue.1, pp.109-131, 1991.
DOI : 10.1016/0360-3016(91)90171-Y

M. V. Graham and J. A. Purdy, Clinical dose???volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC), International Journal of Radiation Oncology*Biology*Physics, vol.45, issue.2, pp.323-332, 1999.
DOI : 10.1016/S0360-3016(99)00183-2

R. Halperin and W. Roa, Setup reproducibility in radiation therapy for lung cancer: a comparison between T-bar and expanded foam immobilization devices, International Journal of Radiation Oncology*Biology*Physics, vol.43, issue.1, pp.211-217, 1999.
DOI : 10.1016/S0360-3016(98)00354-X

T. Knoos and . Kristensen, Volumetric and dosimetric evaluation of radiation treatment plans: radiation conformity index, International Journal of Radiation Oncology*Biology*Physics, vol.42, issue.5, pp.1169-76, 1998.
DOI : 10.1016/S0360-3016(98)00239-9

S. L. Kwa and J. V. Lebesque, Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients, International Journal of Radiation Oncology*Biology*Physics, vol.42, issue.1, pp.1-9, 1998.
DOI : 10.1016/S0360-3016(98)00196-5

R. Oozeer and B. Chauvet, Evaluation dosim??trique d'une radioth??rapie conformationnelle: le facteur de conformation, Cancer/Radioth??rapie, vol.4, issue.3, pp.207-223, 2000.
DOI : 10.1016/S1278-3218(00)89096-4